Tsai-Sheng Yang - Div Hematol & Oncol, Chang Gung Mem Hosp

基本信息

浏览量：45

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 44 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Zinc Supplementation is Associated with Improvement in Hand-Foot Skin Reaction in Patients on Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitors: A Cohort Study

Chun-Wei Lu,Chun-Nan Yeh,Hung- Chih Hsu,Chun-Bing Chen,Tsai-Sheng Yang,Yi -Ru Pan,Wen- Hung Chung,Shuen-Iu Hung

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYno. 4 (2024): 814-815

引用0浏览0WOS引用

Clinical Characteristics and Genetic HLA Marker for Patients with Oxaliplatin-Induced Adverse Drug Reactions

Hung-Chih Hsu,Wen-Hung Chung,Yung-Chang Lin,Tsai-Sheng Yang,John Wen-Cheng Chang,Chia-Hsun Hsieh,Shuen-Iu Hung,Chun-Wei Lu,Jen-Shi Chen,Wen-Chi Chou,Chuang-Wei Wang

Allergology International（2024）

引用0浏览0WOS引用

Abstract CT150: Result of an Open-Label Phase 2 Trial of Dual TORC1/TORC2 Inhibitor Onatasertib (ATG-008) in HBV+ Advanced Hepatocellular Carcinoma (HCC) Subjects Who Have Received at Least One Prior Line of Systemic Therapy (TORCH)

Shukui Qin,Xiaoyan Lin, Zhiqaing Meng,Zhenggang Ren,Yuxian Bai,Shanzhi Gu,Li Zheng,Qiu Li, Sun-Yong Oh,Yabing Guo, Yoong-Koo Kang,Wei-Yu Kao,Wei Li,Jung-Hwan Yoon,Helong Zhang,Pei-Jer Chen,Tsai-Sheng Yang,Jeong Heo,Zhendong Zheng, Hui Xie, Zhinuan Yu

Cancer Researchno. 8_Supplement (2023)

引用0浏览0引用

Prospective, Open-Label, and Observational Study of Cetuximab for Metastatic Colorectal Carcinoma: the OPTIM1SE Study

Tsai-Sheng Yang,Hong-Hwa Chen,Lin Bo-Wen,Tae Won Kim,Jong Gwang Kim,Joong Bae Ahn,Myung-Ah Lee,Johnson Lin,Gwo Fuang Ho,Le Tuan Anh,Sally Temraz,Matthew Burge,Clarinda Chua,Jason Huang,Young Suk Park

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY（2023）

引用0浏览0WOS引用

Result of an open-label phase 2 trial of dual TORC1/TORC2 inhibitor onatasertib (ATG-008) in HBV+ advanced hepatocellular carcinoma (HCC) subjects who have received at least one prior line of systemic therapy (TORCH)

Shukui Qin,Xiaoyan Lin, Zhiqaing Meng,Zhenggang Ren,Yuxian Bai,Shanzhi Gu, Li Zheng,Qiu Li, Sun-Yong Oh,Yabing Guo, Yoong-Koo Kang,Wei-Yu Kao,Wei Li,Jung-Hwan Yoon,Helong Zhang,Pei-Jer Chen,Tsai-Sheng Yang,Jeong Heo,Zhendong Zheng,Hui Xie, Zhinuan Yu

CANCER RESEARCHno. 8 (2023)

引用0浏览0引用

Zinc Supplementation Decreased Incidence of Grade ≥2 Hand-Foot Skin Reaction Induced by Regorafenib: A Phase II Randomized Clinical Trial

Wen-Kuan Huang,Hung-Chih Hsu,Tsai-Sheng Yang,Chun-Wei Lu,Yi -Ru Pan,Chiao-En Wu,Wen-Hung Chung,Shuen-Iu Hung,Chun-Nan Yeh

Journal of the American Academy of Dermatology（2023）

引用1浏览0WOS引用

Camrelizumab Plus Rivoceranib Versus Sorafenib As First-Line Therapy for Unresectable Hepatocellular Carcinoma (CARES-310): a Randomised, Open-Label, International Phase 3 Study

Shukui Qin,Stephen L. Chan,Shanzhi Gu,Yuxian Bai,Zhenggang Ren,Xiaoyan Lin,Zhendong Chen,Weidong Jia,Yongdong Jin,Yabing Guo,Xiaohua Hu,Zhiqiang Meng,Jun Liang,Ying Cheng,Jianping Xiong,Hong Ren, Fang Yang,Wei Li,Yajin Chen,Yong Zeng,Alexander Sultanbaev,Monika Pazgan-Simon, Margaryta Pisetska,Davide Melisi, Dmitriy Ponomarenko, Yurii Osypchuk, Ivan Sinielnikov,Tsai-Sheng Yang, Xiao Liang,Chunxia Chen,Linna Wang,Ann-Lii Cheng,Ahmed Kaseb,Arndt Vogel

The Lancetno. 10408 (2023): 1133-1146

引用208浏览0WOS引用

208

Bevacizumab and Atezolizumab As First-Line Therapy for Advanced Hepatocellular Carcinoma: A Taiwanese Subgroup Analysis on Efficacy and Safety

Yu-Yun Shao,Yin-Hsun Feng,Chia-Jui Yen,Tsai-Sheng Yang,Ying-Chun Shen,Yee Chao,Jen-Shi Chen,Ching-Yen Su, Wei-Jen Chen, Hwa-Lin Hsiang,Chih-Hung Hsu

Journal of the Formosan Medical Association（2022）

引用5浏览0WOS引用

Risk of Cardiovascular Disease among Different Fluoropyrimidine-Based Chemotherapy Regimens As Adjuvant Treatment for Resected Colorectal Cancer

Wen-Kuan Huang, Wei-Pang Ho,Hung-Chih Hsu,Shu-Hao Chang,Dong-Yi Chen,Wen-Chi Chou,Pei-Hung Chang,Jen-Shi Chen,Tsai-Sheng Yang,Lai-Chu See

FRONTIERS IN CARDIOVASCULAR MEDICINE（2022）

引用1浏览0WOS引用

Real-World Effectiveness of Adjuvant Oxaliplatin Chemotherapy in Stage III Colon Cancer: A Controlled Interrupted Time Series Analysis

Wen-Kuan Huang,Hung-Chih Hsu,Shu-Hao Chang,Wen-Chi Chou,Pei-Hung Chang,Sum-Fu Chiang,John Wen-Cheng Chang,Jen-Shi Chen,Tsai-Sheng Yang,Lai-Chu See

Frontiers in Pharmacology（2021）

引用5浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn